Safe in Common has been established to enhance and save the lives of U.S. healthcare personnel at risk of harm from needlestick injuries.
First established in 2010 as an online community of healthcare professionals and other advocates committed to injection safety, Safe in Common will lead a Needlestick Safety Advocacy Tour across the U.S starting March 2012.
The Tour will visit more than 50 leading U.S. hospitals and attend more than a dozen healthcare conferences across 36 metropolitan centers during the first stage of the national campaign.
At each location, Safe in Common representatives will advocate for needlestick safety, record real stories from healthcare personnel and provide demonstrations of the latest safety-engineered medical equipment that can help to deliver optimal protection to those at risk of harm.
Safe in Common is proudly supported by its lead sponsor Unilife, a U.S. based global leader for advanced drug delivery systems.